logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Age at first use distributions and primary drug distributions — EU summary of clients entering treatment, 2009 or most recent year available [see all tables in this series...]

Part (v) New inpatient clients, age at first use distribution by primary drug (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Mean ageAge known (base)Age not known
Hypnotics and sedatives7.818.615.
Volatile substances36.752.
Cannabis 38.844.710.
Other substances 13.927.723.


 Countries reporting data: BG, CZ, DK, DE, IE, EL, FR, CY,HU, NL, AT, PL, RO, SK, FI, SE, UK, HR, TR 

 The number of treatment clients in each country is listed in Table TDI-7

 Last data available from Poland refer to 2008.                       

 See also Table TDI-108 on distribution by country and 'General notes for interpreting data’ on the Explanatory notes and help page


 Reitox national reports 2010 — Table TDI — inpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Wednesday, 29 June 2011